A 6-year-old boy from rural India presents with progressive joint pain, stiffness in the knees and ankles, and dark urine that turns black on standing. His urine reduces Fehling's reagent but is negative on glucose oxidase. Physical examination reveals blue-black discolouration of the sclera and cartilage of the ears. Which investigation is most specific for confirming the diagnosis of alkaptonuria?

Explanation

## Most Specific Investigation: Urine Homogentisic Acid Quantification by HPLC **Key Point:** Urine homogentisic acid quantification by HPLC is the gold-standard and most specific confirmatory test for alkaptonuria. It directly measures the accumulated metabolite that causes the disease phenotype. ### Biochemistry of Alkaptonuria Alkaptonuria is an autosomal recessive disorder of tyrosine metabolism caused by deficiency of the enzyme **homogentisate 1,2-dioxygenase**, which normally catalyzes the conversion of homogentisic acid to maleylacetoacetic acid in the tyrosine degradation pathway. ### Why HPLC Quantification of Urine Homogentisic Acid? 1. **Directly measures the pathogenic metabolite** — homogentisic acid accumulates massively (4–8 g/day in alkaptonuria vs. <100 mg/day in normal individuals) 2. **Highly specific** — no other aminoacidopathy produces such high urinary homogentisic acid levels 3. **Quantitative** — allows severity assessment and monitoring 4. **Confirms the metabolic block** — proves the enzymatic defect in tyrosine catabolism ### Clinical Features Explained by Homogentisic Acid Accumulation | Feature | Mechanism | |---------|----------| | **Dark urine on standing** | Homogentisic acid oxidizes and polymerizes to a black pigment (alkapton) when exposed to air and alkali | | **Ochronosis** (blue-black discolouration of connective tissues) | Alkapton polymer deposits in cartilage, sclera, skin | | **Arthritis (ochronotic arthropathy)** | Pigment deposition in joint cartilage → cartilage degradation, osteoarthritis (typically after age 30) | | **Reduces Fehling's but not glucose oxidase** | Homogentisic acid is a reducing sugar; glucose oxidase is specific for glucose | ### Diagnostic Approach ```mermaid flowchart TD A[Dark urine + ochronosis + arthritis]:::outcome --> B[Urine reduces Fehling's but not glucose oxidase?]:::decision B -->|Yes| C[Urine HPLC for homogentisic acid]:::action C --> D{Homogentisic acid >1000 mg/day?}:::decision D -->|Yes| E[Alkaptonuria confirmed]:::outcome D -->|No| F[Consider other reducing substances]:::outcome B -->|No| G[Exclude other metabolic disorders]:::action ``` **High-Yield:** The triad of **dark urine on standing + ochronosis + progressive arthritis** is pathognomonic for alkaptonuria. HPLC quantification of urine homogentisic acid is the confirmatory gold standard. **Mnemonic:** **OCHA** — **O**chronosis, **C**artilage arthropathy, **H**omogentisic acid accumulation, **A**utosomal recessive. **Clinical Pearl:** Alkaptonuria is one of the first genetic disorders described by Garrod (1902). Unlike PKU, it is benign in childhood; arthropathy develops in the 3rd–4th decade. Management is supportive (NSAIDs, nitisinone in some centres to inhibit homogentisic acid synthesis).